Recombinant Human Erythropoietin (rhEPO) Market Report

Global and Region Recombinant Human Erythropoietin (rhEPO) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：157
  • REPORT CODE：GMM948012
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Recombinant Human Erythropoietin (rhEPO) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Human Erythropoietin (rhEPO)market, defines the market attractiveness level of Recombinant Human Erythropoietin (rhEPO) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Recombinant Human Erythropoietin (rhEPO) industry, describes the types of Recombinant Human Erythropoietin (rhEPO) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Human Erythropoietin (rhEPO) market and the development prospects and opportunities of Recombinant Human Erythropoietin (rhEPO) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Human Erythropoietin (rhEPO) market in Chapter 13.

    By Player:

    • Kyowa Hakko Kirin

    • Shandong Kexing

    • NCPC Genetech

    • Ahua Pharmaceutical

    • 3SBio

    • Biosidus

    • Dragon Pharma

    • Shanghai Chemo

    • Chengdu Diao

    By Type:

    • ESRD

    • Cancer

    • HIV

    • Wounds and neural disease

    By End-User:

    • Hospitals

    • Retail Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Recombinant Human Erythropoietin (rhEPO) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Recombinant Human Erythropoietin (rhEPO) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Recombinant Human Erythropoietin (rhEPO) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Recombinant Human Erythropoietin (rhEPO) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Recombinant Human Erythropoietin (rhEPO) Market Analysis and Outlook to 2022

    • 7.1 Global Recombinant Human Erythropoietin (rhEPO) Consumption (2017-2022)

    • 7.2 United States Recombinant Human Erythropoietin (rhEPO) Consumption (2017-2022)

    • 7.3 Europe Recombinant Human Erythropoietin (rhEPO) Consumption (2017-2022)

    • 7.4 China Recombinant Human Erythropoietin (rhEPO) Consumption (2017-2022)

    • 7.5 Japan Recombinant Human Erythropoietin (rhEPO) Consumption (2017-2022)

    • 7.6 India Recombinant Human Erythropoietin (rhEPO) Consumption (2017-2022)

    • 7.7 South Korea Recombinant Human Erythropoietin (rhEPO) Consumption (2017-2022)

    8 Region and Country-wise Recombinant Human Erythropoietin (rhEPO) Market Analysis and Outlook to 2028

    • 8.1 Global Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2022-2028)

    • 8.2 United States Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2022-2028)

    • 8.3 Europe Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2022-2028)

    • 8.4 China Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2022-2028)

    • 8.5 Japan Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2022-2028)

    • 8.6 India Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2022-2028)

    • 8.7 South Korea Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2022-2028)

    9 Global Recombinant Human Erythropoietin (rhEPO) Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Human Erythropoietin (rhEPO) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global ESRD Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global HIV Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Wounds and neural disease Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Human Erythropoietin (rhEPO) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Recombinant Human Erythropoietin (rhEPO) Market Outlook by Types and Applications to 2028

    • 10.1 Global Recombinant Human Erythropoietin (rhEPO) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global ESRD Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global HIV Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Wounds and neural disease Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Recombinant Human Erythropoietin (rhEPO) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Recombinant Human Erythropoietin (rhEPO) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Recombinant Human Erythropoietin (rhEPO) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Recombinant Human Erythropoietin (rhEPO) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Recombinant Human Erythropoietin (rhEPO) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Recombinant Human Erythropoietin (rhEPO) Market Competitive Analysis

    • 14.1 Kyowa Hakko Kirin

      • 14.1.1 Kyowa Hakko Kirin Company Details

      • 14.1.2 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Product and Service

    • 14.2 Shandong Kexing

      • 14.2.1 Shandong Kexing Company Details

      • 14.2.2 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Product and Service

    • 14.3 NCPC Genetech

      • 14.3.1 NCPC Genetech Company Details

      • 14.3.2 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Product and Service

    • 14.4 Ahua Pharmaceutical

      • 14.4.1 Ahua Pharmaceutical Company Details

      • 14.4.2 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Product and Service

    • 14.5 3SBio

      • 14.5.1 3SBio Company Details

      • 14.5.2 3SBio Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 3SBio Recombinant Human Erythropoietin (rhEPO) Product and Service

    • 14.6 Biosidus

      • 14.6.1 Biosidus Company Details

      • 14.6.2 Biosidus Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Biosidus Recombinant Human Erythropoietin (rhEPO) Product and Service

    • 14.7 Dragon Pharma

      • 14.7.1 Dragon Pharma Company Details

      • 14.7.2 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Product and Service

    • 14.8 Shanghai Chemo

      • 14.8.1 Shanghai Chemo Company Details

      • 14.8.2 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Product and Service

    • 14.9 Chengdu Diao

      • 14.9.1 Chengdu Diao Company Details

      • 14.9.2 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Recombinant Human Erythropoietin (rhEPO)

    • Figure Recombinant Human Erythropoietin (rhEPO) Picture

    • Table Global Recombinant Human Erythropoietin (rhEPO) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Human Erythropoietin (rhEPO) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Human Erythropoietin (rhEPO) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Recombinant Human Erythropoietin (rhEPO) Consumption by Country (2017-2022)

    • Figure United States Recombinant Human Erythropoietin (rhEPO) Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Human Erythropoietin (rhEPO) Consumption and Growth Rate (2017-2022)

    • Figure China Recombinant Human Erythropoietin (rhEPO) Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Human Erythropoietin (rhEPO) Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Human Erythropoietin (rhEPO) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Human Erythropoietin (rhEPO) Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Human Erythropoietin (rhEPO) Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Human Erythropoietin (rhEPO) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Human Erythropoietin (rhEPO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Recombinant Human Erythropoietin (rhEPO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Human Erythropoietin (rhEPO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Human Erythropoietin (rhEPO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Human Erythropoietin (rhEPO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ESRD Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global HIV Consumption and Growth Rate (2017-2022)

    • Figure Global Wounds and neural disease Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global ESRD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Wounds and neural disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Recombinant Human Erythropoietin (rhEPO) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Recombinant Human Erythropoietin (rhEPO) Export by Region (Top 5 Countries) (2017-2028)

    • Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)

    • Table Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Product and Service

    • Table Shandong Kexing (Foundation Year, Company Profile and etc.)

    • Table Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Product and Service

    • Table NCPC Genetech (Foundation Year, Company Profile and etc.)

    • Table NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Product and Service

    • Table Ahua Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Product and Service

    • Table 3SBio (Foundation Year, Company Profile and etc.)

    • Table 3SBio Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3SBio Recombinant Human Erythropoietin (rhEPO) Product and Service

    • Table Biosidus (Foundation Year, Company Profile and etc.)

    • Table Biosidus Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biosidus Recombinant Human Erythropoietin (rhEPO) Product and Service

    • Table Dragon Pharma (Foundation Year, Company Profile and etc.)

    • Table Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Product and Service

    • Table Shanghai Chemo (Foundation Year, Company Profile and etc.)

    • Table Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Product and Service

    • Table Chengdu Diao (Foundation Year, Company Profile and etc.)

    • Table Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US